Literature DB >> 17998118

Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.

Catherine M Glew1, Russell J Rentler.   

Abstract

INTRODUCTION: Many patients are not only prescribed proton pump inhibitors (PPIs) or other acid-suppressive medications (ASMs) during their hospital stay, but are discharged to the nursing facility on these medications. We wanted to quantify the amount of acid-suppressive prescription in new admissions, and how many patients had diagnoses that would justify their use.
METHODS: A chart review of 98 admissions to a 128-bed for-profit nursing facility in Pennsylvania was performed to assess how many patients were transferred on a PPI or H2 blocker. Data were collected on age, sex, and any diagnoses relevant to the prescription of a PPI.
RESULTS: Sixty (61%) of 98 patients had a PPI on their transfer orders to the skilled nursing facility (SNF). An additional 3 patients were on an H(2) receptor antagonist, totaling 64.3% prescribed acid suppression therapy. Only 30 patients (50%) had an appropriate diagnosis in their medical record justifying prescription of an ASM based on our criteria. In addition, 3 (3.1%) of 98 patients had a qualifying diagnosis in their medical records, but were not on PPI or H2 receptor antagonists on admission to the SNF.
CONCLUSION: Many patients admitted to an SNF may be prescribed acid-suppressive therapy with no clear indication. Inappropriate use of PPI therapy should be minimized as overuse will not only increase drug costs, but also the risks of drug side effects and polypharmacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998118     DOI: 10.1016/j.jamda.2007.07.001

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  11 in total

1.  Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.

Authors:  Patrick S Yachimski; Elizabeth A Farrell; Daniel P Hunt; Andrea E Reid
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

3.  Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Lisa A Jackson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

Review 4.  A benefit-risk assessment of the use of proton pump inhibitors in the elderly.

Authors:  Gwen M C Masclee; Miriam C J M Sturkenboom; Ernst J Kuipers
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.

Authors:  Elsa López-Pintor; Blanca Lumbreras
Journal:  Int J Clin Pharm       Date:  2011-03-12

6.  Inappropriate use of proton pump inhibitors in a local setting.

Authors:  Christopher Tze Wei Chia; Wan Peng Lim; Charles Kien Fong Vu
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

7.  Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.

Authors:  Alanna Doell; Ashley Walus; Jaclyn To; Allison Bell
Journal:  Can J Hosp Pharm       Date:  2018-10-31

8.  Acid suppression therapy and allergic reactions.

Authors:  Eva Untersmayr
Journal:  Allergo J Int       Date:  2015-12

9.  Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.

Authors:  Jacob E Kurlander; Joel H Rubenstein; Caroline R Richardson; Sarah L Krein; Raymond De Vries; Brian J Zikmund-Fisher; Yu-Xiao Yang; Loren Laine; Arlene Weissman; Sameer D Saini
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

10.  Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors.

Authors:  Christopher V Almario; William D Chey; Brennan M R Spiegel
Journal:  Am J Gastroenterol       Date:  2020-10       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.